Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Leukemia, Myeloid, Chronic-Phase 6Neoplasm Metastasis 4Neoplasms 3Philadelphia Chromosome 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia 2Synovitis, Pigmented Villonodular 1Sarcoma 1Recurrence 1Peritoneal Neoplasms 1Neoplasm, Residual 1Melanoma 1Leukemia, Myeloid 1Hematologic Diseases 1Giant Cell Tumor of Tendon Sheath 1Genital Neoplasms, Female 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chordoma 1Cholangiocarcinoma 1Breast Neoplasms 1Blast Crisis 1Appendiceal Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Standard of Care 2Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2relacorilant 1nilotinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Therapeutic Touch 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy 1Pregnancy Tests 1Practice Guidelines as Topic 1Paclitaxel 1Nivolumab 1Laparoscopy 1Ipilimumab 1Human Papillomavirus DNA Tests 1Fulvestrant 1Electrocardiography 1Colposcopy 1Cell Count 1Biopsy 1Bevacizumab 1Behavior Therapy 1Acetic Acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × nilotinib × 1 year × Clear all
NCT05185947 2026-05-29

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
21 enrolled 21 charts
BreastGastrointestinalGynecologic

Appendiceal Neoplasms, Breast Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡